Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Varian, a Siemens Healthineers Company
University of California, Irvine
Duke University
University Hospital, Lille
Essen Biotech
Essen Biotech
Angiex, Inc.
New Phase Ltd.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
DualityBio Inc.
Takeda
Second Life Therapeutics
UNC Lineberger Comprehensive Cancer Center
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
EtiraRx Australia Pty Ltd
Washington University School of Medicine
Milton S. Hershey Medical Center
Novita Pharmaceuticals, Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Columbia University
Tvardi Therapeutics, Incorporated
Ruijin Hospital
Intensity Therapeutics, Inc.
Icahn School of Medicine at Mount Sinai
Universidade Federal de Pernambuco
Changhai Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Comprehensive Support Project for Oncology Research
Celldex Therapeutics
Fusion Pharmaceuticals Inc.
Massachusetts General Hospital
Varian, a Siemens Healthineers Company
Klus Pharma Inc.
Celldex Therapeutics
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Chongqing Precision Biotech Co., Ltd
Xencor, Inc.
Qianfoshan Hospital
Quadriga Biosciences, Inc.